title: The authors reply.
authors.affiliation: Division of Pediatric Critical Care, Children's Hospital of Richmond, Richmond, VA; Division of Pediatric Critical Care, Penn State Hershey Children's Hospital, Hershey, PA; Division of Pediatric Critical Care, Children's Hospital and Medical Center, University of Nebraska, Omaha, NE; Department of Internal Medicine, University of Virginia, Charlottesville, VA Department of Public Health Sciences, University of Virginia, Charlottesville, VA Department of Pediatrics, Children's Hospital Cleveland Clinic, Cleveland, OH; ONY Pharmaceuticals, Amherst, NY, and Division of Neonatology at the State University of New York, Buffalo, NY.
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Willson
authors.forename: Neal J
authors.initials: NJ
authors.lastname: Thomas
authors.forename: Robert
authors.initials: R
authors.lastname: Tamburro
authors.forename: Edward
authors.initials: E
authors.lastname: Truemper
authors.forename: Jonathon
authors.initials: J
authors.lastname: Truwit
authors.forename: Mark
authors.initials: M
authors.lastname: Conaway
authors.forename: Christine
authors.initials: C
authors.lastname: Traul
authors.forename: Edmund E
authors.initials: EE
authors.lastname: Egan
mesh_terms: D055371:Acute Lung Injury / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
chemical_list: D001688:Biological Products; D011663:Pulmonary Surfactants